Skip to main content

Ureter Injury

4
Pipeline Programs
2
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Intuitive Surgical
Intuitive SurgicalCA - Sunnyvale
4 programs
2
2
IS-001Phase 31 trial
filricianinePhase 31 trial
IS-001Phase 21 trial
IS-001Phase 21 trial
Active Trials
NCT03937505Completed94Est. Jul 2021
NCT05769257Completed12Est. Apr 2024
NCT05954767Completed189Est. Sep 2025
+1 more trials
MediBeacon
MediBeaconGermany - Mannheim
1 program
LumitracePHASE_11 trial
Active Trials
NCT07080008Recruiting10Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Intuitive Surgicalfilricianine
Intuitive SurgicalIS-001
Intuitive SurgicalIS-001
Intuitive SurgicalIS-001
MediBeaconLumitrace

Clinical Trials (5)

Total enrollment: 451 patients across 5 trials

NCT07346066Intuitive Surgicalfilricianine

IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery

Start: Mar 2026Est. completion: Aug 2027146 patients
Phase 3Not Yet Recruiting
NCT05954767Intuitive SurgicalIS-001

IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery

Start: Jan 2024Est. completion: Sep 2025189 patients
Phase 3Completed
NCT05769257Intuitive SurgicalIS-001

A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery

Start: Jun 2023Est. completion: Apr 202412 patients
Phase 2Completed
NCT03937505Intuitive SurgicalIS-001

A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy

Start: May 2019Est. completion: Jul 202194 patients
Phase 2Completed
NCT07080008MediBeaconLumitrace

Evaluation of Lumitrace for Visualizing Ureters During Abdominopelvic Surgeries

Start: Jan 2026Est. completion: Dec 202610 patients
Phase 1Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 451 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.